Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia

Rank, Cecilie Utke; Lynggaard, Line Stensig; Toft, Nina; Nielsen, Ove Juul; Stock, Wendy; Als‐Nielsen, Bodil; Frandsen, Thomas Leth; Tuckuviene, Ruta; Schmiegelow, Kjeld

doi:10.1002/14651858.cd013399

Search citation statements

Order By: Relevance

Paper Sections

Select...

Thromboembolism1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

2021

Publication Types

Select...

Article2

Relationship

Self Cite2

Independent0

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…apixaban, edoxaban, betrixaban and rivaroxaban), which act independently of AT. There is an unmet need for randomized controlled trials testing these approacheds 101 .…”

Section: Thromboembolismmentioning

confidence: 99%

SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia

Schmiegelow

Rank

Stock

et al. 2021

Clinical Lymphoma Myeloma and Leukemia

Self Cite

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract